| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 4.09e-05 | 15 | 13 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.07e-04 | 24 | 13 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.02e-03 | 739 | 13 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.29e-03 | 83 | 13 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | ribosome binding | 2.68e-03 | 120 | 13 | 2 | GO:0043022 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.09e-03 | 560 | 13 | 3 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 5.24e-03 | 566 | 13 | 3 | GO:0001216 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 7.67e-03 | 206 | 13 | 2 | GO:0043021 | |
| GeneOntologyBiologicalProcess | odontogenesis of dentin-containing tooth | 3.74e-05 | 107 | 13 | 3 | GO:0042475 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 4.06e-05 | 110 | 13 | 3 | GO:2000027 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 5.22e-05 | 351 | 13 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | odontogenesis | 1.04e-04 | 151 | 13 | 3 | GO:0042476 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 1.09e-04 | 25 | 13 | 2 | GO:2001224 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.47e-04 | 29 | 13 | 2 | GO:0045948 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 2.28e-04 | 36 | 13 | 2 | GO:0034063 | |
| GeneOntologyBiologicalProcess | embryonic forelimb morphogenesis | 2.41e-04 | 37 | 13 | 2 | GO:0035115 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.18e-04 | 561 | 13 | 4 | GO:0048568 | |
| GeneOntologyBiologicalProcess | forelimb morphogenesis | 4.07e-04 | 48 | 13 | 2 | GO:0035136 | |
| GeneOntologyBiologicalProcess | cartilage development | 4.23e-04 | 243 | 13 | 3 | GO:0051216 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 4.55e-04 | 1141 | 13 | 5 | GO:0045597 | |
| GeneOntologyBiologicalProcess | embryonic cranial skeleton morphogenesis | 4.78e-04 | 52 | 13 | 2 | GO:0048701 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.04e-04 | 258 | 13 | 3 | GO:0001763 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 6.20e-04 | 277 | 13 | 3 | GO:0048705 | |
| GeneOntologyBiologicalProcess | regulation of neuron migration | 6.79e-04 | 62 | 13 | 2 | GO:2001222 | |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 7.46e-04 | 65 | 13 | 2 | GO:0021872 | |
| GeneOntologyBiologicalProcess | positive regulation of ossification | 7.69e-04 | 66 | 13 | 2 | GO:0045778 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 7.89e-04 | 713 | 13 | 4 | GO:0048598 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell proliferation | 9.14e-04 | 72 | 13 | 2 | GO:2000648 | |
| GeneOntologyBiologicalProcess | regulation of morphogenesis of an epithelium | 1.02e-03 | 76 | 13 | 2 | GO:1905330 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.12e-03 | 1390 | 13 | 5 | GO:0045944 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.15e-03 | 343 | 13 | 3 | GO:0061448 | |
| GeneOntologyBiologicalProcess | cranial skeletal system development | 1.24e-03 | 84 | 13 | 2 | GO:1904888 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell apoptotic process | 1.33e-03 | 87 | 13 | 2 | GO:0010656 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.45e-03 | 91 | 13 | 2 | GO:0006446 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 1.45e-03 | 91 | 13 | 2 | GO:0003281 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 1.49e-03 | 846 | 13 | 4 | GO:0120035 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 1.61e-03 | 863 | 13 | 4 | GO:0031344 | |
| GeneOntologyBiologicalProcess | positive regulation of protein polymerization | 1.82e-03 | 102 | 13 | 2 | GO:0032273 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 2.08e-03 | 109 | 13 | 2 | GO:0048704 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 2.47e-03 | 119 | 13 | 2 | GO:0072091 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 2.68e-03 | 124 | 13 | 2 | GO:0060349 | |
| GeneOntologyBiologicalProcess | regionalization | 2.97e-03 | 478 | 13 | 3 | GO:0003002 | |
| GeneOntologyBiologicalProcess | translational initiation | 3.03e-03 | 132 | 13 | 2 | GO:0006413 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 3.12e-03 | 134 | 13 | 2 | GO:0003279 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 3.27e-03 | 494 | 13 | 3 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell apoptotic process | 3.44e-03 | 141 | 13 | 2 | GO:0010660 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 3.74e-03 | 147 | 13 | 2 | GO:0030278 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 3.78e-03 | 1090 | 13 | 4 | GO:0022603 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 3.79e-03 | 148 | 13 | 2 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 3.79e-03 | 148 | 13 | 2 | GO:0035113 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 3.79e-03 | 148 | 13 | 2 | GO:0048706 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 3.84e-03 | 1095 | 13 | 4 | GO:0060284 | |
| GeneOntologyBiologicalProcess | muscle cell apoptotic process | 3.89e-03 | 150 | 13 | 2 | GO:0010657 | |
| MousePheno | growth retardation of molars | 1.89e-05 | 8 | 12 | 2 | MP:0000128 | |
| MousePheno | small molars | 4.44e-05 | 12 | 12 | 2 | MP:0006402 | |
| MousePheno | abnormal neurocranium morphology | 5.88e-05 | 269 | 12 | 4 | MP:0000074 | |
| MousePheno | delayed cranial suture closure | 6.11e-05 | 14 | 12 | 2 | MP:0010743 | |
| MousePheno | absent stapedial artery | 9.12e-05 | 17 | 12 | 2 | MP:0004666 | |
| MousePheno | short limbs | 1.02e-04 | 111 | 12 | 3 | MP:0000547 | |
| MousePheno | abnormal stapedial artery morphology | 1.27e-04 | 20 | 12 | 2 | MP:0004665 | |
| MousePheno | increased thyroid-stimulating hormone level | 1.27e-04 | 20 | 12 | 2 | MP:0005135 | |
| MousePheno | abnormal basicranium morphology | 1.38e-04 | 123 | 12 | 3 | MP:0010029 | |
| MousePheno | decreased activity of thyroid gland | 1.41e-04 | 21 | 12 | 2 | MP:0003503 | |
| MousePheno | delayed bone ossification | 1.52e-04 | 127 | 12 | 3 | MP:0000060 | |
| MousePheno | small incisors | 1.55e-04 | 22 | 12 | 2 | MP:0030079 | |
| MousePheno | abnormal thyroid follicle morphology | 1.69e-04 | 23 | 12 | 2 | MP:0004696 | |
| MousePheno | decreased triiodothyronine level | 1.69e-04 | 23 | 12 | 2 | MP:0005473 | |
| MousePheno | microdontia | 2.17e-04 | 26 | 12 | 2 | MP:0030088 | |
| MousePheno | delayed intramembranous bone ossification | 2.52e-04 | 28 | 12 | 2 | MP:0003420 | |
| MousePheno | abnormal thyroid gland physiology | 2.90e-04 | 30 | 12 | 2 | MP:0002876 | |
| MousePheno | abnormal stapes morphology | 3.10e-04 | 31 | 12 | 2 | MP:0005107 | |
| MousePheno | abnormal thyroid-stimulating hormone level | 3.51e-04 | 33 | 12 | 2 | MP:0003971 | |
| MousePheno | abnormal triiodothyronine level | 3.73e-04 | 34 | 12 | 2 | MP:0005472 | |
| MousePheno | abnormal forelimb morphology | 4.38e-04 | 182 | 12 | 3 | MP:0000550 | |
| MousePheno | decreased circulating thyroxine level | 4.67e-04 | 38 | 12 | 2 | MP:0005478 | |
| MousePheno | abnormal zygomatic bone morphology | 5.44e-04 | 41 | 12 | 2 | MP:0005270 | |
| MousePheno | decreased circulating levels of thyroid hormone | 5.98e-04 | 43 | 12 | 2 | MP:0003351 | |
| MousePheno | decreased bone mineral density of femur | 7.15e-04 | 47 | 12 | 2 | MP:0020010 | |
| MousePheno | abnormal circulating thyroxine level | 8.41e-04 | 51 | 12 | 2 | MP:0005475 | |
| MousePheno | decreased thyroxine level | 8.41e-04 | 51 | 12 | 2 | MP:0005471 | |
| MousePheno | abnormal molar morphology | 8.41e-04 | 51 | 12 | 2 | MP:0002689 | |
| MousePheno | abnormal eyelid morphology | 9.00e-04 | 233 | 12 | 3 | MP:0001340 | |
| MousePheno | delayed endochondral bone ossification | 9.43e-04 | 54 | 12 | 2 | MP:0003419 | |
| MousePheno | abnormal middle ear ossicle morphology | 1.01e-03 | 56 | 12 | 2 | MP:0005105 | |
| MousePheno | abnormal basisphenoid bone morphology | 1.05e-03 | 57 | 12 | 2 | MP:0000106 | |
| MousePheno | abnormal intramembranous bone ossification | 1.20e-03 | 61 | 12 | 2 | MP:0008273 | |
| MousePheno | abnormal bone mineral density of femur | 1.28e-03 | 63 | 12 | 2 | MP:0020009 | |
| MousePheno | abnormal thyroxine level | 1.41e-03 | 66 | 12 | 2 | MP:0005469 | |
| MousePheno | abnormal temporal bone morphology | 1.41e-03 | 66 | 12 | 2 | MP:0005272 | |
| MousePheno | abnormal outer hair cell stereociliary bundle morphology | 1.49e-03 | 68 | 12 | 2 | MP:0004527 | |
| MousePheno | cleft palate | 1.68e-03 | 289 | 12 | 3 | MP:0000111 | |
| MousePheno | oral cleft | 1.71e-03 | 291 | 12 | 3 | MP:0021164 | |
| MousePheno | abnormal thyroid hormone level | 1.76e-03 | 74 | 12 | 2 | MP:0005468 | |
| MousePheno | decreased compact bone thickness | 2.21e-03 | 83 | 12 | 2 | MP:0000135 | |
| MousePheno | abnormal palate morphology | 2.26e-03 | 321 | 12 | 3 | MP:0003755 | |
| MousePheno | abnormal thyroid gland morphology | 2.43e-03 | 87 | 12 | 2 | MP:0000681 | |
| MousePheno | abnormal cochlear hair cell stereociliary bundle morphology | 2.65e-03 | 91 | 12 | 2 | MP:0004521 | |
| MousePheno | abnormal forelimb stylopod morphology | 2.71e-03 | 92 | 12 | 2 | MP:0003854 | |
| MousePheno | abnormal humerus morphology | 2.71e-03 | 92 | 12 | 2 | MP:0005296 | |
| MousePheno | abnormal middle ear morphology | 2.71e-03 | 92 | 12 | 2 | MP:0000049 | |
| MousePheno | abnormal cranial blood vasculature morphology | 2.89e-03 | 95 | 12 | 2 | MP:0014012 | |
| MousePheno | abnormal sphenoid bone morphology | 2.89e-03 | 95 | 12 | 2 | MP:0000104 | |
| MousePheno | abnormal adaptive thermogenesis | 2.95e-03 | 96 | 12 | 2 | MP:0011019 | |
| MousePheno | decreased amino acid level | 3.01e-03 | 97 | 12 | 2 | MP:0014528 | |
| MousePheno | decreased bone mass | 3.19e-03 | 100 | 12 | 2 | MP:0004016 | |
| MousePheno | decreased bone volume | 3.19e-03 | 100 | 12 | 2 | MP:0010876 | |
| MousePheno | abnormal endochondral bone ossification | 3.71e-03 | 108 | 12 | 2 | MP:0008272 | |
| MousePheno | abnormal tooth development | 3.71e-03 | 108 | 12 | 2 | MP:0000116 | |
| MousePheno | abnormal incisor morphology | 3.85e-03 | 110 | 12 | 2 | MP:0005358 | |
| MousePheno | abnormal cranium morphology | 3.86e-03 | 813 | 12 | 4 | MP:0000438 | |
| MousePheno | abnormal bone ossification | 4.07e-03 | 395 | 12 | 3 | MP:0008271 | |
| MousePheno | abnormal craniofacial bone morphology | 4.11e-03 | 827 | 12 | 4 | MP:0002116 | |
| MousePheno | abnormal joint morphology | 4.13e-03 | 397 | 12 | 3 | MP:0002932 | |
| Domain | YTH | 4.47e-06 | 5 | 13 | 2 | PS50882 | |
| Domain | YTH_domain | 4.47e-06 | 5 | 13 | 2 | IPR007275 | |
| Domain | YTH | 4.47e-06 | 5 | 13 | 2 | PF04146 | |
| Domain | - | 3.27e-04 | 39 | 13 | 2 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.55e-04 | 46 | 13 | 2 | IPR011042 | |
| Domain | EGF | 1.12e-02 | 235 | 13 | 2 | SM00181 | |
| Domain | EGF_3 | 1.12e-02 | 235 | 13 | 2 | PS50026 | |
| Domain | EGF-like_dom | 1.25e-02 | 249 | 13 | 2 | IPR000742 | |
| Domain | EGF_1 | 1.31e-02 | 255 | 13 | 2 | PS00022 | |
| Domain | EGF-like_CS | 1.37e-02 | 261 | 13 | 2 | IPR013032 | |
| Domain | EGF_2 | 1.41e-02 | 265 | 13 | 2 | PS01186 | |
| Domain | Homeodomain-like | 2.16e-02 | 332 | 13 | 2 | IPR009057 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 28106076 | ||
| Pubmed | Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury. | 1.29e-07 | 2 | 13 | 2 | 39081030 | |
| Pubmed | 1.29e-07 | 2 | 13 | 2 | 38250152 | ||
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 35093879 | ||
| Pubmed | YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. | 3.87e-07 | 3 | 13 | 2 | 28106072 | |
| Pubmed | YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation. | 3.87e-07 | 3 | 13 | 2 | 35508130 | |
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 34497675 | ||
| Pubmed | A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA. | 3.87e-07 | 3 | 13 | 2 | 32492408 | |
| Pubmed | Mutant Runx2 regulates amelogenesis and osteogenesis through a miR-185-5p-Dlx2 axis. | 3.87e-07 | 3 | 13 | 2 | 29242628 | |
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 16115867 | ||
| Pubmed | m6A-binding YTHDF proteins promote stress granule formation. | 3.87e-07 | 3 | 13 | 2 | 32451507 | |
| Pubmed | 3.87e-07 | 3 | 13 | 2 | 31292544 | ||
| Pubmed | N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression. | 3.87e-07 | 3 | 13 | 2 | 27371828 | |
| Pubmed | 7.74e-07 | 4 | 13 | 2 | 21678468 | ||
| Pubmed | N6-methyladenosine-dependent regulation of messenger RNA stability. | 7.74e-07 | 4 | 13 | 2 | 24284625 | |
| Pubmed | Context-dependent functional compensation between Ythdf m6A reader proteins. | 1.29e-06 | 5 | 13 | 2 | 32943573 | |
| Pubmed | Spatio-temporal expression of Pbx3 during mouse organogenesis. | 1.93e-06 | 6 | 13 | 2 | 16434237 | |
| Pubmed | Mutation in SSUH2 Causes Autosomal-Dominant Dentin Dysplasia Type I. | 3.61e-06 | 8 | 13 | 2 | 27680507 | |
| Pubmed | Mesenchymal patterning by Hoxa2 requires blocking Fgf-dependent activation of Ptx1. | 3.61e-06 | 8 | 13 | 2 | 12810588 | |
| Pubmed | Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo. | 5.79e-06 | 10 | 13 | 2 | 21924256 | |
| Pubmed | 6.37e-06 | 1429 | 13 | 6 | 35140242 | ||
| Pubmed | SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. | 1.00e-05 | 13 | 13 | 2 | 16751105 | |
| Pubmed | 1.00e-05 | 13 | 13 | 2 | 26047795 | ||
| Pubmed | Requirement for Twist1 in frontonasal and skull vault development in the mouse embryo. | 1.17e-05 | 14 | 13 | 2 | 19414008 | |
| Pubmed | 1.17e-05 | 14 | 13 | 2 | 12000792 | ||
| Pubmed | R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. | 1.35e-05 | 15 | 13 | 2 | 18256198 | |
| Pubmed | Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal development. | 1.75e-05 | 17 | 13 | 2 | 21494559 | |
| Pubmed | 1.75e-05 | 17 | 13 | 2 | 22411303 | ||
| Pubmed | 1.75e-05 | 17 | 13 | 2 | 21531785 | ||
| Pubmed | 1.97e-05 | 18 | 13 | 2 | 33192541 | ||
| Pubmed | 1.97e-05 | 18 | 13 | 2 | 21558373 | ||
| Pubmed | 2.17e-05 | 472 | 13 | 4 | 38943005 | ||
| Pubmed | m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs. | 2.20e-05 | 19 | 13 | 2 | 36039295 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.47e-05 | 1038 | 13 | 5 | 26673895 | |
| Pubmed | Resolving organoid brain region identities by mapping single-cell genomic data to reference atlases. | 2.97e-05 | 22 | 13 | 2 | 33711282 | |
| Pubmed | 2.97e-05 | 22 | 13 | 2 | 15342729 | ||
| Pubmed | 3.54e-05 | 24 | 13 | 2 | 32186512 | ||
| Pubmed | 3.54e-05 | 24 | 13 | 2 | 35179492 | ||
| Pubmed | The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | 3.85e-05 | 25 | 13 | 2 | 35874829 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 4.01e-05 | 552 | 13 | 4 | 10737800 | |
| Pubmed | 4.17e-05 | 26 | 13 | 2 | 14960276 | ||
| Pubmed | 7.62e-05 | 35 | 13 | 2 | 37269288 | ||
| Pubmed | ISLET1-Dependent β-Catenin/Hedgehog Signaling Is Required for Outgrowth of the Lower Jaw. | 7.62e-05 | 35 | 13 | 2 | 28069742 | |
| Pubmed | 1.12e-04 | 260 | 13 | 3 | 36199071 | ||
| Pubmed | 1.14e-04 | 723 | 13 | 4 | 34133714 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.15e-04 | 724 | 13 | 4 | 36232890 | |
| Pubmed | 1.20e-04 | 733 | 13 | 4 | 34672954 | ||
| Pubmed | 2.28e-04 | 331 | 13 | 3 | 20634891 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 2.39e-04 | 877 | 13 | 4 | 20211142 | |
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 3.16e-04 | 71 | 13 | 2 | 8751373 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.30e-04 | 954 | 13 | 4 | 36373674 | |
| Pubmed | 3.49e-04 | 383 | 13 | 3 | 19453261 | ||
| Pubmed | 3.52e-04 | 75 | 13 | 2 | 29459360 | ||
| Interaction | CNOT1 interactions | 3.30e-05 | 305 | 13 | 4 | int:CNOT1 | |
| Interaction | CNOT11 interactions | 4.59e-05 | 112 | 13 | 3 | int:CNOT11 | |
| Interaction | CNOT7 interactions | 8.92e-05 | 140 | 13 | 3 | int:CNOT7 | |
| Interaction | CNOT10 interactions | 9.11e-05 | 141 | 13 | 3 | int:CNOT10 | |
| Interaction | CPEB4 interactions | 1.23e-04 | 156 | 13 | 3 | int:CPEB4 | |
| Interaction | EPHA8 interactions | 1.56e-04 | 169 | 13 | 3 | int:EPHA8 | |
| Interaction | CEP85 interactions | 1.56e-04 | 169 | 13 | 3 | int:CEP85 | |
| Interaction | ISX interactions | 1.77e-04 | 31 | 13 | 2 | int:ISX | |
| Interaction | CNOT2 interactions | 1.82e-04 | 178 | 13 | 3 | int:CNOT2 | |
| Interaction | ZFP36 interactions | 1.91e-04 | 181 | 13 | 3 | int:ZFP36 | |
| Interaction | ALG13 interactions | 1.97e-04 | 183 | 13 | 3 | int:ALG13 | |
| Interaction | DZIP3 interactions | 1.97e-04 | 183 | 13 | 3 | int:DZIP3 | |
| Interaction | AGO1 interactions | 1.97e-04 | 183 | 13 | 3 | int:AGO1 | |
| Interaction | QKI interactions | 2.20e-04 | 190 | 13 | 3 | int:QKI | |
| Interaction | MSX2 interactions | 2.38e-04 | 195 | 13 | 3 | int:MSX2 | |
| Interaction | PDPK1 interactions | 2.67e-04 | 203 | 13 | 3 | int:PDPK1 | |
| Interaction | CNOT3 interactions | 2.83e-04 | 207 | 13 | 3 | int:CNOT3 | |
| Interaction | TDRD3 interactions | 3.04e-04 | 212 | 13 | 3 | int:TDRD3 | |
| Interaction | SMURF1 interactions | 3.09e-04 | 544 | 13 | 4 | int:SMURF1 | |
| Interaction | MEN1 interactions | 3.14e-04 | 1029 | 13 | 5 | int:MEN1 | |
| Interaction | KLK2 interactions | 3.26e-04 | 42 | 13 | 2 | int:KLK2 | |
| Interaction | ACOX3 interactions | 3.26e-04 | 42 | 13 | 2 | int:ACOX3 | |
| Interaction | CNOT9 interactions | 3.91e-04 | 231 | 13 | 3 | int:CNOT9 | |
| Interaction | FURIN interactions | 5.21e-04 | 255 | 13 | 3 | int:FURIN | |
| Interaction | COPS2 interactions | 5.39e-04 | 258 | 13 | 3 | int:COPS2 | |
| Interaction | LSM14A interactions | 5.52e-04 | 260 | 13 | 3 | int:LSM14A | |
| Interaction | PRRC2B interactions | 5.83e-04 | 265 | 13 | 3 | int:PRRC2B | |
| Interaction | KLK3 interactions | 6.66e-04 | 60 | 13 | 2 | int:KLK3 | |
| Interaction | HES1 interactions | 7.57e-04 | 64 | 13 | 2 | int:HES1 | |
| Interaction | SKP2 interactions | 8.04e-04 | 296 | 13 | 3 | int:SKP2 | |
| Interaction | CEP128 interactions | 8.12e-04 | 297 | 13 | 3 | int:CEP128 | |
| Interaction | EIF4ENIF1 interactions | 8.36e-04 | 300 | 13 | 3 | int:EIF4ENIF1 | |
| Interaction | GCM1 interactions | 8.54e-04 | 68 | 13 | 2 | int:GCM1 | |
| Interaction | CTH interactions | 9.05e-04 | 70 | 13 | 2 | int:CTH | |
| Interaction | B9D2 interactions | 9.84e-04 | 73 | 13 | 2 | int:B9D2 | |
| Interaction | SMG7 interactions | 9.99e-04 | 319 | 13 | 3 | int:SMG7 | |
| Interaction | CNOT8 interactions | 1.01e-03 | 74 | 13 | 2 | int:CNOT8 | |
| Interaction | MUSK interactions | 1.01e-03 | 74 | 13 | 2 | int:MUSK | |
| Interaction | SETD1B interactions | 1.04e-03 | 75 | 13 | 2 | int:SETD1B | |
| Interaction | SECISBP2 interactions | 1.12e-03 | 78 | 13 | 2 | int:SECISBP2 | |
| Interaction | BTRC interactions | 1.17e-03 | 775 | 13 | 4 | int:BTRC | |
| Interaction | CARMIL1 interactions | 1.24e-03 | 82 | 13 | 2 | int:CARMIL1 | |
| Interaction | WAC interactions | 1.27e-03 | 83 | 13 | 2 | int:WAC | |
| Interaction | NR0B2 interactions | 1.27e-03 | 83 | 13 | 2 | int:NR0B2 | |
| Interaction | R3HDM1 interactions | 1.30e-03 | 84 | 13 | 2 | int:R3HDM1 | |
| Interaction | PAX2 interactions | 1.33e-03 | 85 | 13 | 2 | int:PAX2 | |
| Interaction | IFITM1 interactions | 1.36e-03 | 355 | 13 | 3 | int:IFITM1 | |
| Interaction | MEF2D interactions | 1.39e-03 | 87 | 13 | 2 | int:MEF2D | |
| Interaction | CNOT6L interactions | 1.59e-03 | 93 | 13 | 2 | int:CNOT6L | |
| Interaction | GRIN2A interactions | 1.59e-03 | 93 | 13 | 2 | int:GRIN2A | |
| Interaction | ZNF608 interactions | 1.59e-03 | 93 | 13 | 2 | int:ZNF608 | |
| Interaction | DMRTB1 interactions | 1.62e-03 | 94 | 13 | 2 | int:DMRTB1 | |
| Interaction | DCAF4 interactions | 1.63e-03 | 378 | 13 | 3 | int:DCAF4 | |
| Interaction | INTS14 interactions | 1.66e-03 | 95 | 13 | 2 | int:INTS14 | |
| Interaction | CTSG interactions | 1.66e-03 | 95 | 13 | 2 | int:CTSG | |
| Interaction | CLEC11A interactions | 1.69e-03 | 96 | 13 | 2 | int:CLEC11A | |
| Interaction | MKRN2 interactions | 1.72e-03 | 385 | 13 | 3 | int:MKRN2 | |
| Interaction | SOX9 interactions | 1.73e-03 | 97 | 13 | 2 | int:SOX9 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 4.62e-05 | 432 | 13 | 4 | M41149 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 9.24e-05 | 836 | 13 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 176 | 13 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 189 | 13 | 3 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-05 | 194 | 13 | 3 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 6.04e-04 | 127 | 13 | 2 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.52e-04 | 151 | 13 | 2 | 9ebfbdccc9656fce8990d06622f225009633f07c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.52e-04 | 151 | 13 | 2 | 29d91a7d1470121af45fb8bb35175f2acced4551 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-04 | 154 | 13 | 2 | bd283c2367afb99294e7576a0c0167eb7c69ad6b | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-04 | 158 | 13 | 2 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-04 | 158 | 13 | 2 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | critical-Epithelial-unknown_epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.67e-04 | 161 | 13 | 2 | 594cf3245ec065a7685db81cd8ba2cee8d42caac | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-04 | 163 | 13 | 2 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.91e-04 | 163 | 13 | 2 | e4077e587895c85bc806be05ff5d451088e39468 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-03 | 164 | 13 | 2 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 166 | 13 | 2 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 166 | 13 | 2 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-03 | 166 | 13 | 2 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 166 | 13 | 2 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-03 | 168 | 13 | 2 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 171 | 13 | 2 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-03 | 172 | 13 | 2 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-03 | 172 | 13 | 2 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-03 | 173 | 13 | 2 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-03 | 173 | 13 | 2 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-03 | 173 | 13 | 2 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 175 | 13 | 2 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-03 | 175 | 13 | 2 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 175 | 13 | 2 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-03 | 176 | 13 | 2 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 176 | 13 | 2 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-03 | 176 | 13 | 2 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-03 | 177 | 13 | 2 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-03 | 177 | 13 | 2 | ffc4c675b25ffe8bd3441ce26dd0984fef4b3b88 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.17e-03 | 177 | 13 | 2 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-03 | 177 | 13 | 2 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-03 | 177 | 13 | 2 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-03 | 178 | 13 | 2 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-03 | 178 | 13 | 2 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-03 | 178 | 13 | 2 | f2766913de010b718ba3799996d658b8f499adc5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-03 | 179 | 13 | 2 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-03 | 179 | 13 | 2 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-03 | 179 | 13 | 2 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-03 | 179 | 13 | 2 | df6d2cdc4e204ce1a4628dc71dfbc5e6c6309b2a | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 179 | 13 | 2 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-03 | 180 | 13 | 2 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-03 | 180 | 13 | 2 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.22e-03 | 181 | 13 | 2 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 181 | 13 | 2 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 181 | 13 | 2 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 181 | 13 | 2 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-03 | 181 | 13 | 2 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 181 | 13 | 2 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-03 | 182 | 13 | 2 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-03 | 182 | 13 | 2 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-03 | 182 | 13 | 2 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-03 | 183 | 13 | 2 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-03 | 183 | 13 | 2 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-03 | 183 | 13 | 2 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.25e-03 | 183 | 13 | 2 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-03 | 183 | 13 | 2 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 184 | 13 | 2 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-03 | 184 | 13 | 2 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 184 | 13 | 2 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-03 | 184 | 13 | 2 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-03 | 184 | 13 | 2 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-03 | 185 | 13 | 2 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-03 | 185 | 13 | 2 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-03 | 186 | 13 | 2 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-03 | 186 | 13 | 2 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-03 | 186 | 13 | 2 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-03 | 187 | 13 | 2 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-03 | 187 | 13 | 2 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-03 | 187 | 13 | 2 | 01393f6d1983eb4a2bcc80252012f77892851679 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-03 | 188 | 13 | 2 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-03 | 188 | 13 | 2 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-03 | 188 | 13 | 2 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-03 | 188 | 13 | 2 | 921a2c9212a0f2a00fd72c594d80924f27e8b9b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-03 | 189 | 13 | 2 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-03 | 189 | 13 | 2 | 4e61f9cd1c06bddb47ebf98affc0f97770e26e8c | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-03 | 189 | 13 | 2 | a618a1ddf5097a010c6c2c7341f3a0bd46a29c02 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-03 | 189 | 13 | 2 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-03 | 190 | 13 | 2 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-03 | 191 | 13 | 2 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-03 | 192 | 13 | 2 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-03 | 192 | 13 | 2 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 192 | 13 | 2 | 03dcd9405d3d76fc7455066ba5d83c09cd17072d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-03 | 193 | 13 | 2 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 1.38e-03 | 193 | 13 | 2 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.38e-03 | 193 | 13 | 2 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-03 | 193 | 13 | 2 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-03 | 193 | 13 | 2 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 193 | 13 | 2 | 55eab7d2574e9cc2ed8f08e0a7ca7cbf90fb5818 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-03 | 193 | 13 | 2 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| Computational | Neighborhood of FANCG | 4.08e-04 | 167 | 10 | 3 | MORF_FANCG | |
| Drug | tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A | 3.88e-06 | 200 | 13 | 4 | 375_UP | |
| Drug | bis(I,I-trifluoroacetoxy)iodobenzene | 1.21e-04 | 29 | 13 | 2 | CID000102317 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.27e-04 | 178 | 13 | 3 | 5779_UP | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 1.51e-04 | 189 | 13 | 3 | 3084_UP | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.61e-04 | 193 | 13 | 3 | 7238_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 1.61e-04 | 193 | 13 | 3 | 7057_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.61e-04 | 193 | 13 | 3 | 6730_UP | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.64e-04 | 194 | 13 | 3 | 7214_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.66e-04 | 195 | 13 | 3 | 2805_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 4281_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 3817_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 3256_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 3255_DN | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.69e-04 | 196 | 13 | 3 | 7470_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; HL60; HG-U133A | 1.69e-04 | 196 | 13 | 3 | 1735_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 1.71e-04 | 197 | 13 | 3 | 6867_UP | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 13 | 3 | 6482_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; PC3; HT_HG-U133A | 1.71e-04 | 197 | 13 | 3 | 4014_UP | |
| Drug | monastrol; Up 200; 20uM; MCF7; HG-U133A | 1.71e-04 | 197 | 13 | 3 | 605_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; HL60; HT_HG-U133A | 1.74e-04 | 198 | 13 | 3 | 2487_UP | |
| Drug | monastrol; Up 200; 100uM; PC3; HG-U133A | 1.74e-04 | 198 | 13 | 3 | 668_UP | |
| Drug | Azaperone [1649-18-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.74e-04 | 198 | 13 | 3 | 5877_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; MCF7; HG-U133A | 1.74e-04 | 198 | 13 | 3 | 406_DN | |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.74e-04 | 198 | 13 | 3 | 3790_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.76e-04 | 199 | 13 | 3 | 6771_UP | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.76e-04 | 199 | 13 | 3 | 6687_UP | |
| Drug | Dichlororibofuranosylbenzimidazole | 2.09e-04 | 38 | 13 | 2 | ctd:D004004 | |
| Drug | AC1NDQQF | 3.07e-04 | 46 | 13 | 2 | CID004630071 | |
| Drug | diethylenetriaminepentaacetic acid | 3.93e-04 | 52 | 13 | 2 | CID000003053 | |
| Drug | vitamin K2 | 6.52e-04 | 67 | 13 | 2 | CID000004056 | |
| Drug | Mal.4 | 7.52e-04 | 72 | 13 | 2 | CID000122821 | |
| Drug | ethyl methanesulfonate | 1.77e-03 | 111 | 13 | 2 | CID000006113 | |
| Drug | (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | 2.17e-03 | 472 | 13 | 3 | ctd:C517041 | |
| Drug | NSC401575 | 2.39e-03 | 129 | 13 | 2 | CID000003165 | |
| Drug | Plant Oils | 2.50e-03 | 496 | 13 | 3 | ctd:D010938 | |
| Drug | m(7)GpppG | 2.92e-03 | 143 | 13 | 2 | CID000121958 | |
| Drug | calcium phosphate | 3.16e-03 | 149 | 13 | 2 | CID000024441 | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.55e-03 | 158 | 13 | 2 | 4136_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.73e-03 | 162 | 13 | 2 | 7340_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.96e-03 | 167 | 13 | 2 | 6047_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.00e-03 | 168 | 13 | 2 | 4365_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT_HG-U133A | 4.05e-03 | 169 | 13 | 2 | 6724_UP | |
| Drug | titanium | 4.10e-03 | 170 | 13 | 2 | CID000023963 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.14e-03 | 171 | 13 | 2 | 991_UP | |
| Drug | hydroxyapatite | 4.14e-03 | 171 | 13 | 2 | CID000014781 | |
| Drug | dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A | 4.19e-03 | 172 | 13 | 2 | 584_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 4.43e-03 | 177 | 13 | 2 | 3060_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; PC3; HT_HG-U133A | 4.53e-03 | 179 | 13 | 2 | 4541_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.53e-03 | 179 | 13 | 2 | 4217_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.58e-03 | 180 | 13 | 2 | 1477_UP | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.38e-05 | 14 | 12 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | disease of metabolism (implicated_via_orthology) | 3.17e-05 | 21 | 12 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 1.77e-03 | 156 | 12 | 2 | C0376634 | |
| Disease | anthropometric measurement | 2.05e-03 | 168 | 12 | 2 | EFO_0004302 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTSYAPYGTSSSPAN | 116 | Q07687 | |
| SSPYYYSSTSRPSAP | 426 | Q06710 | |
| SNSPSTHRSYSYRPY | 1506 | O75581 | |
| SPYSSSSSSYYSPDG | 1651 | A7KAX9 | |
| PFQTSSTPYLYYGTS | 436 | Q13950 | |
| YTSPYSPNASSPYSS | 196 | Q9P270 | |
| GYYRNIYTPPDSSTS | 1931 | Q9UKZ4 | |
| TQSSAYSSSYGYPPS | 146 | Q7Z739 | |
| YSPTSPSYSPTSPSY | 1636 | P24928 | |
| YSPTSPSYSPTSPSY | 1671 | P24928 | |
| YSPTSPSYSPTSPSY | 1706 | P24928 | |
| YSPTSPNYSPTSPNY | 1741 | P24928 | |
| YTPTSPNYSPTSPSY | 1776 | P24928 | |
| SYSPTSPSYSPSSPR | 1796 | P24928 | |
| YTPQSPTYTPSSPSY | 1811 | P24928 | |
| SSPSYSPSSPSYSPA | 1821 | P24928 | |
| ESYYSPSYAQSSPGA | 896 | O15014 | |
| LPASYSYSYSSPFSS | 296 | Q9BXU3 | |
| AYPNTPYISSASSYT | 906 | O94979 | |
| QTQSSAYGSSYTYPP | 141 | Q9BYJ9 |